Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SAXAGLIPTIN vs SCOPOLAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SAXAGLIPTIN vs SCOPOLAMINE: Safety Overview

Metric SAXAGLIPTIN SCOPOLAMINE
Total FAERS Reports 2,468 2,747
Deaths Reported 263 219
Death Rate 10.7% 8.0%
Hospitalizations 838 497
Average Patient Age 65.5 yrs 49.3 yrs
% Female Patients 47.8% 70.8%
FDA Approval Date Jul 31, 2009 Approved Prior to Jan 1, 1982
Manufacturer Glenmark Pharmaceuticals Inc., USA Bryant Ranch Prepack
Route ORAL TRANSDERMAL
Marketing Status Discontinued Prescription